About WebBasedCME.com
Applying the latest technological advances in education and message broadcasting, WebBasedCME.com will distribute
ease-of-access pertinent information directly to the professionals that desire to keep up-to-date with medical
breakthroughs.
more...
More Online CME Resources
The Caring For Diabetes Educational Forum
Case Based CME - The Amazing Race to Tight Glycemic Control
American Academy of Family Physicians
Medscape - CME Center
Activities
CME Activities.
DIABETES :: Monograph
Peak Issues (Issue 3): Clinical Use Of Incretin-Based Therapies To Treat Type 2 Diabetes [GLP-1 Receptor Agonists: Strategies for PPG Control]
This program is intended for endocrinologists, diabetologists, and other healthcare professionals (HCPs) who frequently treat patients with type 2 diabetes. This publication series will explore the science of PPG and its contribution to glycemic control, and highlight recent and emerging therapies that address this important target.
This program is intended for endocrinologists, diabetologists, and other healthcare professionals (HCPs) who frequently treat patients with type 2 diabetes. This publication series will explore the science of PPG and its contribution to glycemic control, and highlight recent and emerging therapies that address this important target.
DIABETES :: Webcast Series
The Evolving Landscape of Incretin-Based Therapies: Evaluating Recent Data and Its Clinical Applications
Type 2 diabetes is a progressive disease that often requires treatment intensification using several therapeutic agents. Incretin-based therapies address numerous pathophysiologic defects in type 2 diabetes with limited side effects.This content will discuss incretin-based therapies in depth, from pathophysiologic effects to clinical use, and will incorporate interactive questions whereby you can evaluate your answers against those of your colleagues, along with a concluding faculty panel discussion.
Type 2 diabetes is a progressive disease that often requires treatment intensification using several therapeutic agents. Incretin-based therapies address numerous pathophysiologic defects in type 2 diabetes with limited side effects.This content will discuss incretin-based therapies in depth, from pathophysiologic effects to clinical use, and will incorporate interactive questions whereby you can evaluate your answers against those of your colleagues, along with a concluding faculty panel discussion.
DIABETES :: Online Case Study
Cases in Practice: Incretin-Based Therapies for Common Patient Encounters
This activity is composed of 3 interactive case studies which explore options for the clinical use of incretin-based therapies in diverse clinical scenarios. Because each case study examines different aspects of diabetes care, completion of all 3 is expected to provide a broader perspective regarding the use of the 2 available classes of incretin-based therapies.
This activity is composed of 3 interactive case studies which explore options for the clinical use of incretin-based therapies in diverse clinical scenarios. Because each case study examines different aspects of diabetes care, completion of all 3 is expected to provide a broader perspective regarding the use of the 2 available classes of incretin-based therapies.
DIABETES :: Monograph
Peak Issues (Issue 2): Clinical Use Of Incretin-Based Therapies To Treat Type 2 Diabetes
This program is intended for endocrinologists, diabetologists, and other healthcare professionals (HCPs) who frequently treat patients with type 2 diabetes. This publication series will explore the science of PPG and its contribution to glycemic control, and highlight recent and emerging therapies that address this important target.
This program is intended for endocrinologists, diabetologists, and other healthcare professionals (HCPs) who frequently treat patients with type 2 diabetes. This publication series will explore the science of PPG and its contribution to glycemic control, and highlight recent and emerging therapies that address this important target.
DIABETES :: Webcast Series
Breaking the Cycle: Using Incretin-Based Therapies to Overcome Clinical Inertia in Type 2 Diabetes
Incretin-based therapies, with their unique pathophysiology, have rapidly evolved into a therapeutic option that can fill this role. The symposium content, enhanced with an audience response system (ARS) and a case-based panel discussion, will concentrate on various critical aspects of successful type 2 diabetes disease management. Patient selection and strategies for advancement to incretin-based therapies are among the topics that will be discussed.
Incretin-based therapies, with their unique pathophysiology, have rapidly evolved into a therapeutic option that can fill this role. The symposium content, enhanced with an audience response system (ARS) and a case-based panel discussion, will concentrate on various critical aspects of successful type 2 diabetes disease management. Patient selection and strategies for advancement to incretin-based therapies are among the topics that will be discussed.
DIABETES :: Monograph
Peak Issues: Clinical Use Of Incretin-Based Therapies To Promote PPG Control In Type 2 Diabetes
This publication series will explore the science of PPG and its contribution to glycemic control, and highlight recent and emerging therapies that address this important target.
This publication series will explore the science of PPG and its contribution to glycemic control, and highlight recent and emerging therapies that address this important target.
DIABETES :: Monograph
Incretin Insider: Incretin Mimetics 2008 in Review
A wealth of new data on incretin mimetics were released and published in 2008. This publication will summarize these key findings and offer insight into the clinical utility of incretin mimetics. This activity is intended for endocrinologists as well as other physicians and healthcare professionals treating patients with type 2 diabetes.
A wealth of new data on incretin mimetics were released and published in 2008. This publication will summarize these key findings and offer insight into the clinical utility of incretin mimetics. This activity is intended for endocrinologists as well as other physicians and healthcare professionals treating patients with type 2 diabetes.
INFLUENZA :: Teaching Kit
Antiviral Therapy for Influenza - A Case-Based Approach for Optimal Management
Infectious disease specialists frequently act as consultants to primary care physicians and are therefore ideally qualified, by virtue of their training and function within the healthcare system, to educate their colleagues on this topic. This Teaching Kit provides several tools you can use to help other physicians address the multifaceted challenges of influenza management in view of recent guideline updates.
Infectious disease specialists frequently act as consultants to primary care physicians and are therefore ideally qualified, by virtue of their training and function within the healthcare system, to educate their colleagues on this topic. This Teaching Kit provides several tools you can use to help other physicians address the multifaceted challenges of influenza management in view of recent guideline updates.
DIABETES :: Online Case Study
3 Online Interactive Cases: The Amazing Race to Tight Glycemic Control
Interactive Online CME Cases from IMP's ADA 2008 Symposium entitled 'THE AMAZING RACE to Tight Glycemic Control: Managing Complex Patients With Insulin Analogs'
Interactive Online CME Cases from IMP's ADA 2008 Symposium entitled 'THE AMAZING RACE to Tight Glycemic Control: Managing Complex Patients With Insulin Analogs'
DIABETES :: Monograph
Breaking News on Incretin-Based Therapies: Summary Conference Report
In Conjunction with the 2008 American Diabetes Association's 68th Annual Scientific Sessions this educational activity is designed to increase awareness and understanding of the role of incretin-based therapies in the treatment of patients with type 2 diabetes.
In Conjunction with the 2008 American Diabetes Association's 68th Annual Scientific Sessions this educational activity is designed to increase awareness and understanding of the role of incretin-based therapies in the treatment of patients with type 2 diabetes.
DIABETES :: Webcast Series
Managing FPG and PPG With Incretin-Based Therapies
In the area of clinical management of diabetes, an urgent and ongoing need for appropriate treatment remains. In order to effectively manage this widespread disease, clinical professionals need to fully understand diabetes and its treatment options.
In the area of clinical management of diabetes, an urgent and ongoing need for appropriate treatment remains. In order to effectively manage this widespread disease, clinical professionals need to fully understand diabetes and its treatment options.
SEPSIS :: Applied Practical Learning
Early Identification and Treatment Protocols in Managing Severe Sepsis
This program will feature discussions by leading experts regarding severe sepsis recognition and management in adult patients. Participants will learn about current and emerging methods for early identification of severe sepsis, benefits of protocols for managing the condition, and resources for protocol development and implementation.
This program will feature discussions by leading experts regarding severe sepsis recognition and management in adult patients. Participants will learn about current and emerging methods for early identification of severe sepsis, benefits of protocols for managing the condition, and resources for protocol development and implementation.
DIABETES :: Webcast Series
Type 2 Diabetes: Pathophysiologic Challenges, Incretin Solutions
Incretin-based therapies not only offer the potential to address many of the pathophysiologic challenges of type 2 diabetes but also show great promise in addressing clinical challenges. This educational program will provide current information on pathophysiologic challenges in type 2 diabetes and potential solutions offered by incretin-based therapies.
Incretin-based therapies not only offer the potential to address many of the pathophysiologic challenges of type 2 diabetes but also show great promise in addressing clinical challenges. This educational program will provide current information on pathophysiologic challenges in type 2 diabetes and potential solutions offered by incretin-based therapies.
OBESITY :: Applied Practical Learning
Cardiometabolic Risk Reduction in the Metabolic Syndrome and Type 2 Diabetes
This activity was developed for physicians, nurses, and pharmacists involved in the management of patients with obesity and cardiometabolic risk factors.
INSOMNIA :: Podcast Series
Redefining Insomnia: State-of-the-Science in Insomnia Management
This activity was developed for primary care physicians, psychiatrists, pharmacists, and other healthcare professionals involved in the
management of patients with chronic insomnia.
This activity was developed for primary care physicians, psychiatrists, pharmacists, and other healthcare professionals involved in the
management of patients with chronic insomnia.
INSOMNIA :: Monograph
Redefining Insomnia: State-of-the-Science in Insomnia Management
This activity was developed for primary care physicians, psychiatrists, pharmacists, and other healthcare professionals involved in the
management of patients with chronic insomnia.
This activity was developed for primary care physicians, psychiatrists, pharmacists, and other healthcare professionals involved in the
management of patients with chronic insomnia.
INSOMNIA :: Applied Practical Learning
Redefining Insomnia: State-of-the-Science in Insomnia Management
This activity was developed for primary care physicians, psychiatrists, pharmacists, and other healthcare professionals involved in the
management of patients with chronic insomnia.
This activity was developed for primary care physicians, psychiatrists, pharmacists, and other healthcare professionals involved in the
management of patients with chronic insomnia.
